Bicycle raises $61M in downsized IPO, joining fellow biotechs on Nasdaq who have hauled in $1.6B collectively
A splashy syndicate, some big name partnerships and a technology designed to deliver a therapeutic payload more precisely have enticed public investors to Bicycle Therapeutics …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.